Combination therapy with naltrexone and bupropion for obesity

Obesity Prevalence in the United States — Up, Down, or Sideways?

(2011) Susan Z. Yanovski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects

(2009) Charles S. Wilcox et al.   ADDICTIVE BEHAVIORS

WHO recognition of the global obesity epidemic

(2009) W P T James   INTERNATIONAL JOURNAL OF OBESITY

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo

(2009) Frank L. Greenway et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis

(2009) A. N. Fabricatore et al.   Obesity Reviews

The epidemiology of obesity: the size of the problem

(2008) W. P. T. James   JOURNAL OF INTERNAL MEDICINE

In This Issue

(2008)   Obesity

Rational Design of a Combination Medication for the Treatment of Obesity

(2008) Frank L. Greenway et al.   Obesity